A Phase III Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD)
Status:
Completed
Trial end date:
2017-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the equivalence of JR-131 to Darbepoetin alfa and
evaluate the safety of JR-131 in renal anemia patients with chronic kidney disease (CKD).